A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Aztreonam Impurity 13 - Request Quote

Picture of Aztreonam Impurity 13

Aztreonam Impurity 13

SZ CAT No:SZ-A072031
CAS No
NA
Mol.F.
C13H17N5O8S2
Mol.Wt.
435.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Aztreonam Impurity 13 is chemically 2-((((Z)-1-(2-aminothiazol-4-yl)-2-(((2R,3R)-2-methyl-4-oxo-1-sulfoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid. Aztreonam Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Aztreonam Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aztreonam.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Aztreonam Impurity 13

Purchase Aztreonam Impurity 13

Aztreonam Impurity 13 suppliers

Aztreonam Impurity 13 manufacturers

Aztreonam Impurity 13 price

Order Aztreonam Impurity 13

Enquire Aztreonam Impurity 13

Aztreonam Impurity 13 cost

Aztreonam Impurity 13 Supplier

Aztreonam Impurity 13 Distributor

Aztreonam Impurity 13 for Method Validation

Aztreonam Reference Standard

Aztreonam Impurity 13 for ANDA Filing

Aztreonam Impurity 13 for Forced Degradation Studies

Aztreonam Impurity 13 Identification Standards

Aztreonam Impurity 13 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,